Randomized Phase 2b Trial of Tofacitinib (CP-690,550) in De Novo Kidney Transplant Patients: Efficacy, Renal Function and Safety at 1 Year

2012160 citationsJournal Articlebronze Open Access

Authors

Good health and well-being

Published in: American Journal of Transplantation

Volume 12, Issue 9, pp. 2446-2456

Field-Weighted Citation Impact: 15.03